Insider · CIK 0001204787

MEANWELL CLIVE

Reports to the SEC for 7 companies · BURLINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001204787

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	GUTSFRACTYL HEALTH, INC. · Stock OptionA Award	Director	AAward	+22.5K sh	—	—	22,500
2025-11-13	MTSRMetsera, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, EXECUTIVE CHAIRMAN	DDisposition to Issuer	−32.3K sh	—	—	0
2025-11-13	MTSRMetsera, Inc.D Disposition to Issuer	Director, EXECUTIVE CHAIRMAN	DDisposition to Issuer	−12.8M sh	—	—	0
2025-11-13	MTSRMetsera, Inc. · Restricted Stock UnitA Award	Director, EXECUTIVE CHAIRMAN	AAward	+5,375 sh	—	—	5,375
2025-11-13	MTSRMetsera, Inc.D Disposition to Issuer	Director, EXECUTIVE CHAIRMAN	DDisposition to Issuer	−5,375 sh	—	—	0
2025-11-13	MTSRMetsera, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, EXECUTIVE CHAIRMAN	DDisposition to Issuer	−298K sh	—	—	0
2025-06-11	GUTSFRACTYL HEALTH, INC. · Stock OptionA Award	Director	AAward	+22.5K sh	—	—	22,500
2025-05-20	MTSRMetsera, Inc. · Stock Option (Right to Buy)A Award	Director, EXECUTIVE CHAIRMAN	AAward	+32.3K sh	—	—	32,250
2024-02-06	GUTSFRACTYL HEALTH, INC.C Conversion	Director	CConversion	+278K sh	—	—	277,890
2024-02-06	GUTSFRACTYL HEALTH, INC. · Series F Preferred StockC Conversion	Director	CConversion	−596K sh	—	—	0
2024-02-01	GUTSFRACTYL HEALTH, INC. · Stock OptionA Award	Director	AAward	+45K sh	—	—	45,000
2023-11-09	EQRx, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−314K sh	—	—	0
2023-11-09	EQRx, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−101K sh	—	—	0
2023-11-09	EQRx, Inc.Earn-out SharesD Disposition to Issuer	Director	DDisposition to Issuer	−43.2K sh	—	—	0
2023-05-23	IVVDInvivyd, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2023-01-01	EQRx, Inc.Earn-out SharesA Award	Director	AAward	+226 sh	—	—	43,172
2022-09-30	EQRx, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+101K sh	—	—	101,010
2022-06-22	IVVDInvivyd, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+150K sh	—	—	150,000
2021-12-17	EQRx, Inc.Earn-out SharesA Award	Director	AAward	+42.9K sh	—	—	42,946
2021-12-17	EQRx, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+314K sh	—	—	313,500
2021-08-24	Population Health Investment Co., Inc.Warrants to purchase Class A Ordinary ShareP Purchase	Director, Chief Executive Officer	PPurchase	+20K sh	$0.79	+$15.8K	20,000
2021-08-24	Population Health Investment Co., Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,100 sh	$9.79	+$49.9K	16,400
2021-08-24	Population Health Investment Co., Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+11.3K sh	$9.80	+$111K	11,300
2020-01-06	MEDICINES CO /DED Disposition to Issuer	Director, Chief Innovation Officer	DDisposition to Issuer	−480K sh	—	—	0
2020-01-06	MEDICINES CO /DEStock OptionD Disposition to Issuer	Director, Chief Innovation Officer	DDisposition to Issuer	−298K sh	—	—	0
2020-01-06	MEDICINES CO /DEStock OptionD Disposition to Issuer	Director, Chief Innovation Officer	DDisposition to Issuer	−117K sh	—	—	0
2020-01-06	MEDICINES CO /DEStock OptionD Disposition to Issuer	Director, Chief Innovation Officer	DDisposition to Issuer	−95K sh	—	—	0
2020-01-06	MEDICINES CO /DEStock OptionD Disposition to Issuer	Director, Chief Innovation Officer	DDisposition to Issuer	−211K sh	—	—	0
2020-01-06	MEDICINES CO /DEStock OptionD Disposition to Issuer	Director, Chief Innovation Officer	DDisposition to Issuer	−87.8K sh	—	—	0
2020-01-06	MEDICINES CO /DEStock OptionD Disposition to Issuer	Director, Chief Innovation Officer	DDisposition to Issuer	−234K sh	—	—	0
2020-01-06	MEDICINES CO /DEStock OptionD Disposition to Issuer	Director, Chief Innovation Officer	DDisposition to Issuer	−120K sh	—	—	0
2020-01-06	MEDICINES CO /DEStock OptionD Disposition to Issuer	Director, Chief Innovation Officer	DDisposition to Issuer	−117K sh	—	—	0
2020-01-06	MEDICINES CO /DEStock OptionD Disposition to Issuer	Director, Chief Innovation Officer	DDisposition to Issuer	−234K sh	—	—	0
2019-12-27	MEDICINES CO /DEM Exercise/Conversion	Director, Chief Innovation Officer	MExercise/Conversion	+60K sh	$7.31	+$439K	350,810
2019-12-27	MEDICINES CO /DEF Tax Payment	Director, Chief Innovation Officer	FTax Payment	−330K sh	$84.78	−$28M	502,685
2019-12-27	MEDICINES CO /DEStock OptionM Exercise/Conversion	Director, Chief Innovation Officer	MExercise/Conversion	−150K sh	—	—	0
2019-12-27	MEDICINES CO /DEStock OptionM Exercise/Conversion	Director, Chief Innovation Officer	MExercise/Conversion	−15.6K sh	—	—	0
2019-12-27	MEDICINES CO /DEStock OptionM Exercise/Conversion	Director, Chief Innovation Officer	MExercise/Conversion	−64.6K sh	—	—	0
2019-12-27	MEDICINES CO /DEM Exercise/Conversion	Director, Chief Innovation Officer	MExercise/Conversion	+240K sh	$17.45	+$4.19M	606,430
2019-12-27	MEDICINES CO /DEStock OptionM Exercise/Conversion	Director, Chief Innovation Officer	MExercise/Conversion	−11.5K sh	—	—	120,000
2019-12-27	MEDICINES CO /DEM Exercise/Conversion	Director, Chief Innovation Officer	MExercise/Conversion	+64.6K sh	$31.49	+$2.03M	820,998
2019-12-27	MEDICINES CO /DEM Exercise/Conversion	Director, Chief Innovation Officer	MExercise/Conversion	+11.5K sh	$30.55	+$351K	832,481
2019-12-27	MEDICINES CO /DEF Tax Payment	Director, Chief Innovation Officer	FTax Payment	−22.3K sh	$84.78	−$1.89M	480,340
2019-12-27	MEDICINES CO /DEM Exercise/Conversion	Director, Chief Innovation Officer	MExercise/Conversion	+150K sh	$22.04	+$3.31M	756,430
2019-12-27	MEDICINES CO /DEM Exercise/Conversion	Director, Chief Innovation Officer	MExercise/Conversion	+15.6K sh	$13.54	+$211K	366,430
2019-12-27	MEDICINES CO /DEStock OptionM Exercise/Conversion	Director, Chief Innovation Officer	MExercise/Conversion	−60K sh	—	—	0
2019-12-27	MEDICINES CO /DEStock OptionM Exercise/Conversion	Director, Chief Innovation Officer	MExercise/Conversion	−240K sh	—	—	0
2019-08-30	MEDICINES CO /DEA Award	Director, Chief Innovation Officer	AAward	+491 sh	$21.60	+$10.6K	290,810
2019-04-25	MEDICINES CO /DEF Tax Payment	Director, Chief Innovation Officer	FTax Payment	−2,796 sh	$30.48	−$85.2K	290,319
2019-03-04	MEDICINES CO /DEF Tax Payment	Director, Chief Innovation Officer	FTax Payment	−3,586 sh	$25.53	−$91.6K	296,077

Recent filings

Accepted (ET)
Jun 114
MEANWELL CLIVE0001193125-26-267839
SEC(opens sec.gov)
Nov 134
MEANWELL CLIVE0001193125-25-280795
SEC(opens sec.gov)
Jun 134
MEANWELL CLIVE0000950170-25-086153
SEC(opens sec.gov)
May 224
MEANWELL CLIVE0000950170-25-076581
SEC(opens sec.gov)
Feb 84
MEANWELL CLIVE0000950170-24-012842
SEC(opens sec.gov)
Feb 54
MEANWELL CLIVE0000950170-24-011340
SEC(opens sec.gov)
Nov 94
MEANWELL CLIVE0000899243-23-020293
SEC(opens sec.gov)
May 254
MEANWELL CLIVE0000899243-23-013916
SEC(opens sec.gov)
Jan 44
MEANWELL CLIVE0001104659-23-001107
SEC(opens sec.gov)
Oct 44
MEANWELL CLIVE0001104659-22-106009
SEC(opens sec.gov)
Jun 244
MEANWELL CLIVE0000899243-22-024047
SEC(opens sec.gov)
Dec 204
MEANWELL CLIVE0000899243-21-049099
SEC(opens sec.gov)

Companies

Address

3 VAN DE GRAAFF DRIVE SUITE 200

BURLINGTON, MA, 01803